Agrobacterium tumefaciens BlcR represses transcription of the blcABC operon, which is involved in metabolism of c-butyrolactone, and this repression is alleviated by succinate semialdehyde (SSA). BlcR exists as a homodimer, and the blcABC promoter DNA contains two BlcR-binding sites (IR1 and IR2) that correspond to two BlcR dimers. In this study, we established an in vivo system to examine the SSA-responsive control of BlcR transcriptional regulation. The endogenous blcR, encoded in the pAtC58 plasmid of A. tumefaciens C58, was not optimal for investigating the effect of SSA on BlcR repression, probably due to the SSA degradation mediated by the pAt-encoded blcABC. We therefore introduced blcR (and the blcABC promoter DNA, separately) exogenously into a strain of C58 cured of pAtC58 (and pTiC58). We applied this system to interrogate BlcR-DNA interactions and to test predictions from our prior structural and biochemical studies. This in vivo analysis confirmed the previously mapped SSA-binding site and supported a model by which DNA coordinates formation of a BlcR tetramer. In addition, we identified a specific lysine residue (K59) as an important determinant for DNA binding. Moreover, based on isothermal titration calorimetry analysis, we found IR1 to play the dominant role in binding to BlcR, relative to IR2. Together, these in vivo results expand the biochemical findings and provide new mechanistic insights into BlcR-DNA interactions.
INTRODUCTION
Many bacteria adapt to environmental changes via transcriptional regulation of specific genes. The IclR-type family of proteins, found in a broad range of bacteria, is a recently defined class of transcriptional regulators Molina-Henares et al., 2006) . IclR-type regulators are responsive to low-molecular-mass ligands, which usually serve as cues reflecting environmental or physiological changes, and subsequently alter their DNAbinding activities. Proteins of the IclR family are involved in regulation of diverse cellular processes, including metabolism (Sunnarborg et al., 1990; Brune et al., 2007) , multidrug resistance (Guazzaroni et al., 2007b) , aromatic compound degradation (Romero-Steiner et al., 1994; Tsoi et al., 1999) , pathogenicity (Reverchon et al., 1991) and sporulation (Jiang & Kendrick, 2000; Traag et al., 2004; Yamazaki et al., 2003) . Despite their important regulatory roles and the increasing evidence of their profound influence on a variety of cellular and physiological processes, there is a limited understanding of the molecular mechanism(s) by which IclR proteins function.
The BlcR (formerly AttJ) protein of Agrobacterium tumefaciens has served as an experimentally tractable model for molecular analysis of the IclR protein family. BlcR is a negative regulator of the blcABC operon, and its DNA binding ability is affected by succinate semialdehyde (SSA), its cognate effector (Carlier et al., 2004; Wang et al., 2006; Chai et al., 2007) . The blcABC operon is responsible for the catabolism of c-butyrolactone (GBL) (Carlier et al., 2004; Wang et al., 2006; Chai et al., 2007) , and enables A. tumefaciens to utilize GBL, commonly found in plant extracts, as a carbon and energy source. Intriguingly, BlcC, a lactonase, also efficiently degrades the A. tumefaciens acylhomoserine lactone (AHL) quorum-sensing signal, and exerts a profound influence on this intercellular signalling process (Carlier et al., 2004; Zhang et al., 2002) . In our recent structural and biochemical studies (Pan et al., 2011) , we solved the crystal structure of the dimeric BlcR and identified residues important for SSA binding via mutagenesis. Two BlcR dimers bind to a DNA sequence, proximal to the blcABC promoter that contains two pairs of inverted repeats (IRs) with a short inter-IR gap. We also showed that BlcR tetramerizes on binding to DNA, and that DNA plays a scaffold role for BlcR tetramerization and thereby promotes BlcR-DNA interaction. Studies using a BlcR mutant (BlcR F147A ), which is locked in a tetrameric form, support the allosteric mechanism of SSA action on BlcR via interfering with BlcR tetramerization, a process required for effective BlcR-DNA interaction. In this study, we have performed in vivo analyses to examine this molecular model of SSA-regulated BlcR transcriptional control.
METHODS
Strains, plasmids and growth conditions. The genome of A. tumefaciens C58 includes two large plasmids, pTiC58 and pAtC58. C58 At + /Ti 2 refers to a derivative in which pTiC58 has been cured and C58 p 2 refers to the strain with both pTiC58 and pAtC58 cured. All the bacterial strains and plasmids used in this study are listed in Table 1 . Fragments containing A. tumefaciens C58 wild-type blcR or mutated versions of the blcR gene were amplified from plasmids pQE-BlcR or pTB146-BlcR (Pan et al., 2011) using Phusion DNA polymerase. PCR fragments were purified using a PCR purification kit (Qiagen), excised with NdeI and BamHI restriction enzymes and ligated into the compatibly cleaved vector pSRKGm so that the inserted gene is under the control of the lac promoter (P lac -blcR, Gm r ), termed pCL6, or pCL6-blcR mut . A DNA fragment of 800 bp containing the blcABC promoter (P blcA ) region was amplified from A. tumefaciens A6 genomic DNA and fused, with BamHI and PstI sites, to lacZ (P blcA -lacZ, Sp r ) on the vector pRA301, to create pCL8. The P blcA fragment was designed to insert the promoter region and ribosome-binding site with the start codon of the blcA gene in-frame with the lacZ coding sequence. Plasmids pCL8-49 bp, pCL8-50 bp, pCL8-52 bp and pCL8-53 bp were generated by incorporating sitespecific point mutations in the inter-IR gap region of P blcA in accordance with our previous study (Pan et al., 2011) using the QuikChange kit (Stratagene). All plasmid constructs and mutations were confirmed by DNA sequencing. Plasmids were electroporated into A. tumefaciens using a standard method (Mersereau et al., 1990 (Tempé et al., 1977) at 28 uC. Escherichia coli strains were grown in LB medium at 37 uC. Transformants with appropriate antibiotic resistance were selected [pCL6 or its derivatives with gentamicin (Gm) selection and pCL8 or its derivatives with spectinomycin (Sp) selection]. The final antibiotic concentrations were: for A. tumefaciens, 300 mg Gm ml 21 , 300 mg Sp ml
21
; and for E. coli, 100 mg ampicillin (Ap) ml
, 30 mg Gm ml 21 , 100 mg Sp ml
.
Assay of b-galactosidase activity (Miller, 1972) . Cells for bgalactosidase assay were cultured from a fresh single colony in 2 ml ATGN medium in the presence of desired amounts of SSA (pH 7.0, Sigma-Aldrich) and appropriate concentrations of IPTG at 28 uC to an OD 600 of approximately 1.0 (the actual OD 600 was recorded). Then, 0.1 ml cell culture was mixed with 0.9 ml Z-buffer (60 mM Na 2 HPO 4 , 40 mM NaH 2 PO 4 , 10 mM KCl, 1 mM MgSO 4 , 50 mM bmercaptoethanol, pH 7.0), 35 ml 0.05 % SDS and 30 ml chloroform. The sample was manually shaken vigorously for 30 s to facilitate cell lysis and 100 ml of a 4 mg ml 21 solution of the colorimetric reagent ONPG (Sigma) was added to the lysed culture. The reactions were incubated at room temperature and timed from the point of ONPG addition until the solution was medium yellow or if no yellow colour appeared within several hours, and the reaction was terminated by adding 600 ml 1 M Na 2 CO 3 and the reaction time recorded. After centrifuging the sample at 13 000 r. Isothermal titration calorimetry (ITC). To generate the DNA duplex, the single-stranded oligonucleotide and its complementary oligonucleotide (Integrated DNA Technologies) were incubated at 98 uC, and the temperature was slowly decreased to allow optimal annealing. ITC experiments were carried out at 25 uC in a VP-ITC titration calorimeter system (MicroCal). A total of 30 aliquots of 10 ml samples of y200 mM BlcR F147A (in monomeric form) were injected into the DNA solution (y5 mM) at 420 s intervals. Proteins and DNA were analysed in 50 mM Tris/HCl, pH 7.5, 300 mM NaCl and 0.5 mM EDTA. Data were processed with Origin (OriginLab), and the baseline-corrected binding isotherm was used to derive thermodynamic parameters of the binding process.
RESULTS
Induction of the blcABC promoter using A. tumefaciens C58 At
To develop an appropriate A. tumefaciens derivative for in vivo analyses of the SSA response of BlcR, we evaluated the activity of the native blcR gene encoded on the resident pAtC58 plasmid using the P blcA -lacZ-containing reporter pCL8. As shown in Fig. 1 (a) (inset), when pCL8 was introduced into A. tumefaciens C58 At + /Ti 2 , a minimal bgalactosidase activity (approximately 5 MU) was observed suggesting the possibility that the endogenous BlcR was repressing the P blcA -lacZ fusion on pCL8. When using the isogenic A. tumefaciens C58 p 2 (cured of pAtC58) without resident blcR, a drastic increase in b-galactosidase activity was observed for this same P blcA -lacZ fusion plasmid [~95 MU, Fig. 1(a) (inset) ], supporting the model that the pAtC58-encoded blcR repressed P blcA -lacZ activity. Next, we examined how SSA affected the repression of the pAtC58-encoded blcR on P blcA -lacZ. A range of SSA concentrations were added exogenously to C58 At + /Ti 2 at the time of inoculation, and b-galactosidase activity was found to increase with SSA concentration, to as high as sixfold at 2 mM SSA. This amount of expression is 30 % that of the fully derepressed P blcA -lacZ activity in the C58 p 2 derivative, in which blcR is not present (~100 MU, with or without SSA) [ Fig. 1 (a) (inset)]. Above this SSA concentration there was substantial growth inhibition, suggesting a detrimental effect of excess SSA on cellular viability. To assess the SSA effect on blcR activity at high concentrations, we allowed A. tumefaciens cells to grow to a cell density of OD 600 51.0, added a range of SSA concentrations to cell cultures and continued cell growth for three more hours before assaying for b-galactosidase activity. Although b-galactosidase activity appeared to increase with SSA concentration, its maximal value of approximately 45 MU at 5 mM SSA was much less than that expected for full derepression. The inability of SSA to fully derepress the pAtC58-encoded blcR on P blcA -lacZ might reflect the contribution of SSA degradation by the pAtC58-encoded BlcABC degradation system.
Ectopic plasmid-borne expression of blcR provides SSA-modulated repression of the blcABC promoter
In order to circumvent any potential problems of blcABCmediated SSA degradation or endogenous blcR expression control, we constructed a plasmid to express the blcR regulator from the lac promoter (P lac -blcR, pCL6), which also carries the lac repressor (lacI) and therefore provides IPTG control of expression. To study BlcR function, we introduced this blcR expression plasmid into A. tumefaciens C58 p 2 harbouring pCL8 (P blcA -lacZ) and tested b-galactosidase activity as a function of IPTG concentration. Induction of blcR expression with 100 mM IPTG repressed the P blcA -lacZ activity to a level (approximately 5 MU, Fig. 1b ) similar to that observed in C58 At Fig. 1 (a) in which blcR is supplied from its native location on pAtC58, suggesting that expression of the pCL6-borne blcR was induced in a range at or above that of the wild-type copy. Note that this amount of the P lac inducer had no effect on the strain harbouring the vector control instead of blcR (grey bars in Fig. 1b ). Importantly, in direct contrast to the pAt-encoded blcR, activity of the pCL6-borne blcR induced with 100 mM IPTG was completely inhibited by 1 mM SSA (Fig. 2) , a concentration below the threshold of 2 mM at which SSA is inhibitory to cell growth (Fig. 1a) . Thus, unless stated otherwise in subsequent experiments, A. tumefaciens C58 p 2 (pCL8 pCL6) was used to study the effect of SSA on BlcR activity, and 100 mM IPTG was used to induce expression of pCL6-borne wild-type or mutant blcR. In vivo analysis of BlcR mutants compromised for SSA interactions
BlcR residues Y133, F147, T158, D210 and C220 are important for SSA binding, based on structural and biochemical studies (Pan et al., 2011) . Individual mutation of these residues to Ala resulted in proteins that maintained wild-type repressive activity on P blcA (Fig. 2) . Consistent with our prior biochemical analyses, this suggests that these mutations did not weaken DNA binding of BlcR (Pan et al., 2011) . Mutations of D210A or C220A abolish SSA binding to BlcR and the Y133A mutation decreases SSA binding affinity by approximately 25-fold (Pan et al., 2011) . The three mutants maintained repression of P blcA even in the presence of 2 mM SSA (Fig. 2) . BlcR T158A appeared to partially respond to SSA, with 58 % (51 MU) and 68 % (75.2 MU) of the level of derepression of wild-type in the presence of 1 and 2 mM SSA, respectively. These findings suggest a weakened affinity of BlcR T158A for SSA. Interestingly, the approximately 50 % derepression displayed by BlcR T158A in the presence of 1 mM SSA correlates well with ITC analysis showing that this protein binds SSA with 50 % the affinity of wild-type BlcR [dissociation constant (K d of 1.6 and 0.7 mM, respectively)] (Pan et al., 2011) . Lastly, we have isolated a BlcR mutant that is apparently locked in a tetrameric form (BlcR F147A ) which mimics the DNA-bound BlcR (Pan et al., 2011) . Also in that study, we have shown that SSA-bound BlcR F147A retains a tight interaction with DNA based on ITC. Consistently, despite the presence of inducing levels of SSA (1-2 mM SSA), the blcR F147A mutant continued to repress the P blcA promoter, as indicated by low b-galactosidase activity (8.8±0.3 MU). Taken together, these in vivo analyses are consistent with our structural and biochemical observations, providing additional support for the role of key SSA binding site residues for interactions between BlcR and SSA and in the tetramerization of BlcR in binding to its DNA target site. Cultures of strain C58 p" (pCL8 pCL6) (black columns) for which different IPTG concentrations were added at the beginning of growth were assayed for b-galactosidase activity. At least three biological replicates were performed for each experiment in (a) and (b), and error bars indicate SD. Strain C58 p" (pCL8) (grey columns) was utilized as the negative control.
In vivo studies of SSA effect on BlcR-DNA interaction in BlcR-DNA interaction, this position was mutated to Ala (K59A) and the regulatory activity of BlcR K59A on P blcA was analysed using the P blcA -lacZ fusion. Induction of blcR K59A did not repress P blcA , as its associated b-galactosidase activity was the same as that of the control without blcR (94.8±5.7 MU; Fig. 2 ). The observation that BlcR K59A did not repress the P blcA promoter suggests that K59 is an important residue for DNA-binding activity of BlcR.
The role of the BlcR target site associated with the blcABC promoter
The DNA sequence proximal to the P blcA promoter (Chai et al., 2007) plays an important role in binding BlcR by mediating formation of the DNA-binding, active, tetrameric form of BlcR (Pan et al., 2011) . The 51 bp DNA sequence we have identified in the BlcR-DNA binding study consists of two IR pairs (Fig. 3a) , with each IR functioning as a binding element for one BlcR dimer, and with the two IRs separated by three base pairs. Our prior ITC measurements have shown that when the inter-IR distance is increased or decreased by 2 or 1 bp (+2, +1, 21 and 22 bp), DNA fragments with such altered inter-IR distance do not bind the dimeric BlcR wt . However, we have found that the modified binding site sequences (+2, +1 and 21 bp) retain high affinity to the preassembled, tetrameric BlcR F147A .
To confirm these in vitro findings, we modified the promoter P blcA in pCL8 accordingly and examined the interaction of both BlcR wt and BlcR F147A with the modified P blcA promoters via b-galactosidase activity. When two base pairs (GG) were inserted into the space between the two IRs (Fig. 3a) , repression by BlcR wt on the modified P blcA+2 promoter was relieved by approximately 15-fold as compared with the wild-type P blcA (Fig. 3b) . In contrast, repression by BlcR F147A on P blcA+2 was relieved only modestly by around twofold, compared with the wild-type promoter. When the inter-IR distance was either increased or decreased by 1 bp, repression by BlcR wt on both P blcA+1 and P blcA21 was approximately 10-fold weaker than on P blcA . In comparison, repression activity by BlcR F147A on both modified promoters remained relatively strong (Fig.  3b) . Thus, repression activity of dimeric BlcR wt was more significantly affected by the inter-IR spacing in P blcA than was tetrameric BlcR F147A . These in vivo observations, along with the biochemical analyses, argue for the important structural role of DNA in orchestrating formation of the DNA-binding, active BlcR tetramer. In vivo mutational analyses on the SSA-and DNA-binding sites. IPTG (100 mM) and the indicated concentration of SSA were included at the beginning of culture growth, C58 p " (pCL8 pCL6) or C58 p " (pCL8 pCL6-blcR mut ) strains (black columns), were grown until OD 600~1 .0 and the b-galactosidase activity was measured. Strain C58 p " (pCL8 pSRKGm), which does not contain the blcR gene, was utilized as the negative control, and since its b-galactosidase activities under various concentrations of SSA were approximately 100 MU (±10 MU), their activities were set to 100 % to facilitate data comparison and interpretation. At least three biological replicates were performed for each experiment, and error bars indicate SDs. Effects of altering the inter-IR distance on P blcA on BlcR transcriptional activity. IPTG (100 mM) was included at the beginning of culture growth, strains were grown to OD 600~1 .0 and bgalactosidase activity was measured. No SSA was included in the experiments. As in Fig. 2 , strain C58 p " (pCL8 pSRKGm), which does not contain the blcR gene, was included as the negative control, and its b-galactosidase activity was set to 100 %. At least three biological replicates were performed for each experiment, and SDs are shown as error bars. In vivo studies of SSA effect on BlcR-DNA interaction When two base pairs (CA) were omitted from the original 3 bp inter-IR gap, wild-type BlcR did not repress expression from this promoter at all (Fig. 3b) , suggesting that interaction between BlcR and the modified P blcA22 was completely abolished. Strikingly, BlcR F147A also failed to inhibit P blcA22, in contrast to its inhibition of the other blcA promoters, wild-type and modified (P blcA+2 , P blcA+1 and P blcA21 ). To extend our in vivo observations, we deleted the two base pairs in the inter-IR region in the 51 bp DNA sequence used in our earlier biochemical studies and measured binding of this 49 bp DNA to BlcR F147A by ITC. No interaction of the 49 bp DNA and BlcR F147A was detected (Fig. 3c) , in direct contrast to strong binding of other 51 bp derivatives (53, 52 and 50 bp; Fig. 3d for an example).
The above findings with BlcR F147A provide information on BlcR recognition pattern in target DNA. To test the hypothesis that the sequence in IR1 has greater effect on BlcR-DNA interaction than that in IR2, we examined binding of BlcR to a 39 bp DNA fragment that included an intact IR1 but a 39-truncated IR2 (see Fig. 3a ). BlcR F147A bound this 39 bp DNA with a similar affinity as the cognate 51 bp fragment (K d 86±14 nM, Fig. 4(a) ; and 54±6 nM (Pan et al., 2011) , respectively). In a different experiment, when the positions of IR1 and IR2 were switched (Fig. 3a) , the 51 bp variant did not bind to BlcR wt nor to tetrameric BlcR F147A based on ITC measurements (see Fig. 4b for an example). These findings further support the primary role of IR1 in the BlcR-DNA interaction.
DISCUSSION
BlcR belongs to the IclR-type transcriptional family, whose members are involved in a diverse range of important cellular processes. Mechanistic information on how IclR proteins function is scarce. BlcR of A. tumefaciens has served as a tractable system for biochemical and mechanistic investigations, with a well-identified target promoter and the SSA inducing ligand. Here, we have established an in vivo system that allows us to examine the interaction of BlcR with the P blcA promoter. We showed that the pAt-encoded resident blcR was not optimal for examination of the effect of SSA on BlcR function, because only partial derepression of the P blcA promoter could be achieved by addition of exogenous SSA at concentrations not detrimental to cell growth. We therefore used the A. tumefaciens C58 p 2 cured of pAtC58 (and pTiC58) expressing blcR from P lac (pCL6) and the P blcA -lacZ fusion plasmid (pCL8) to evaluate the influence of SSA on BlcRmediated repression at non-inhibitory SSA concentrations. Induction of P lac -blcR at 100 mM IPTG, with 1 mM SSA to relieve this repression, was found to be optimal. We subsequently applied this in vivo system to expand upon results from our earlier biochemical and structural studies and to reveal new mechanistic insights. In particular, K59 appeared to be important for BlcR to bind to the target promoter sequence, as its mutation abolished repression by BlcR. In investigating the role of the inter-IR gap in P blcA on transcriptional activity of BlcR, we showed that the +2, +1 and 21 bp inter-IR modifications drastically reduced repression of BlcR wt as expected, but only modestly affected the repressive activity of tetrameric BlcR truncated IR2, the sequence of which is shown in Fig. 3(a) , titrated with BlcR F147A . (b) ITC studies using a 51 bp DNA fragment with IR2 placed ahead of IR1, the sequence of which is shown in Fig.  3(a) (Fig. 3a) . The secondary role of IR2 relative to IR1 in the overall BlcR-DNA interaction is also consistent with studies of both transcriptional activity and ITC using the BlcR binding sequences with variable inter-IR distance. All modifications to the spacing between IR1 and IR2 decreased the binding and in vivo repression of wild-type BlcR. However, the tetrameric BlcR F147A mutant was able to bind to most of these spacing variants, suggesting that the failure of wildtype BlcR to bind was due to the inability of the altered sites to foster tetramerization. However, the 22 construct in which IR2 is moved two bases closer to IR1 could not be bound by BlcR F147A and wild-type BlcR. Each base pair of spacing alters the position of the BlcR-binding site on the face of the DNA double helix by 36 degrees. Apparently, the BlcR F147A tetramer can better tolerate shifting of the binding site in one direction over the other, probably because the narrower intervening sequence may be sterically blocked in the BlcR F147A fixed tetramer, whereas the outward flexing of the tetramer is better tolerated.
BlcR of A. tumefaciens and TtgV of Pseudomonas putida, the two IclR proteins whose biochemical mechanisms have been characterized at the molecular level, share similar characteristics but also differ in several aspects of their transcriptional regulation. Both target promoters (P blcA and P ttgG ) contain two pairs of IRs arranged consecutively, suggesting a tetrameric binding of the regulator. We have shown in this study and prior work that BlcR exists as dimer in its unbound form yet binds to DNA as a tetramer and that tetramerization of BlcR is structurally orchestrated on the DNA via the specific arrangement of the two BlcRbinding sites (Pan et al., 2011) . In contrast, TtgV is a tetramer but with two conformations, a less stable asymmetrical (R) state when in isolation and a more stable symmetrical (T) state when in complex with DNA (Guazzaroni et al., 2007b; Lu et al., 2010) . Like BlcR, the TtgV monomer folds into two functional domains, the DNA-binding N-terminal domain (NTD) and the ligandbinding C-terminal domain (CTD), which are connected via a linker helix. The helix adopts a straight helical conformation in the symmetrical T state, while it becomes bent and distorted in the R state, resulting in an asymmetrical arrangement of the NTDs relative to their CTDs. The ability of the NTDs to assume different orientations allows TtgV to adopt a configuration that interacts effectively with the two consecutive IR pairs on DNA. Unlike in BlcR-DNA binding, the DNA-bindinginduced conformational change to align TtgV NTDs with IR pairs does not affect the oligomeric state of TtgV, despite small structural adjustments in the tetrameric interface. Differences in the influence of the DNA target site on protein multimerization during BlcR-DNA and TtgV-DNA interactions may account for the divergent mechanisms by which the inducing ligand regulates the DNA-binding activity of BlcR and TtgV. Binding of SSA is proposed to interfere with the DNA-mediated tetramerization of BlcR and, as a result, the DNA-binding, active BlcR tetramer dissociates into the stable, inactive SSA-bound BlcR dimer. The proposed role of SSA in dissociating tetrameric BlcR may be explained by partial overlap of the SSA-binding site and the BlcR tetramerization interface. This model is supported by structural and mutational analyses of the BlcR F147A mutant protein, which is locked in a tetrameric state. The BlcR F147A tetramer binds DNA with 10-fold stronger affinity when compared with the wild-type. Intriguingly, F147 is situated within the SSAbinding site on BlcR: thus the parallel involvement of F147 in two important, yet distinct, functions provides a mechanistic link to relay SSA occupancy into changes in BlcR oligomerization. In contrast, the DNA-binding activity of TtgV is regulated via different mechanisms from that of BlcR and does not involve changes in oligomeric state, as TtgV is a stable tetramer. TtgV appears to recognize a wide range of chemical ligands (Guazzaroni et al., 2005) and may utilize different sets of amino acid residues to interact with different ligands (Guazzaroni et al., 2007a) . One ligand-binding site is proposed to be near the TtgV tetramerization interface, and presumably the bound ligand prevents TtgV CTDs from undergoing the aforementioned conformational adjustments in the tetrameric interface observed for the TtgV-DNA complex. A second ligand-binding site is close to the linker helix, and binding of ligand to this site may prevent the linker helix from adopting the bent conformations, thereby dissociating TtgV from DNA. Thus, although transcriptional regulators of the IclR family may have structural and functional resemblances, they can also utilize different modes of action. These two regulators share the common feature of a tetrameric form which binds to a pair of palindromic DNA target sequences, but alteration of DNA binding activity by
